Yahoo
NasdaqGS - Nasdaq Real Time Price USD

COMPASS Pathways plc (CMPS)

11.57 -0.62 (-5.09%)
At close: October 30 at 4:00:01 PM EDT
11.63 +0.06 (+0.52%)
After hours: October 30 at 7:12:48 PM EDT
Trade CMPS on Coinbase
Chart Range Bar
Loading chart for CMPS

What's happening with CMPS?

1h ago
Powered by Yahoo Scout

COMPASS Pathways is approaching two near-term catalysts: its November 3, 2026 third-quarter updateand planned COMP360 presentations at the November 5–8 neuroscience conference. Recent coverage centers on Phase III progress, a potential rolling new drug application, and the valuation gap between bullish fair-value models and elevated price-to-book multiples.

Powered by Yahoo Scout
  • Previous Close 12.19
  • Open 11.82
  • Bid 8.58 x 200
  • Ask 11.60 x 200
  • Day's Range 11.27 - 11.99
  • 52 Week Range 4.88 - 15.87
  • Volume 2,167,476
  • Avg. Volume 2,654,384
  • Market Cap (intraday) 1.602B
  • Beta (5Y Monthly) 2.56
  • PE Ratio (TTM) --
  • EPS (TTM) -3.76
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 23.75
  • Zacks Rating Neutral

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

compasspathways.com

156

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/31/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

CMPS
72.17%
MSCI WORLD (^990100-USD-STRD)
9.75%

1-Year Return

CMPS
83.65%
MSCI WORLD (^990100-USD-STRD)
10.75%

3-Year Return

CMPS
105.14%
MSCI WORLD (^990100-USD-STRD)
75.63%

5-Year Return

CMPS
72.58%
MSCI WORLD (^990100-USD-STRD)
0.00%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings -253.79M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-200M
-100M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

13.00
23.75 Average
11.57 Current
65.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/7/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 70 -> 65

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -29.08%

  • Return on Equity (ttm)

    -319.07%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -394.19M

  • Diluted EPS (ttm)

    -3.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    433.3M

  • Total Debt/Equity (mrq)

    64.62%

  • Levered Free Cash Flow (ttm)

    249.95M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: